TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 343 filers reported holding TANDEM DIABETES CARE INC in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,209,879 | -20.6% | 154,315 | -5.8% | 0.01% | -22.2% |
| Q2 2023 | $4,041,569 | -32.7% | 163,812 | +10.4% | 0.01% | -35.7% |
| Q1 2023 | $6,005,471 | -7.1% | 148,368 | +2.4% | 0.01% | -17.6% |
| Q4 2022 | $6,463,623 | +26.7% | 144,890 | +36.9% | 0.02% | +21.4% |
| Q3 2022 | $5,101,000 | -21.3% | 105,845 | -3.4% | 0.01% | -12.5% |
| Q2 2022 | $6,483,000 | -75.5% | 109,529 | -51.9% | 0.02% | -42.9% |
| Q1 2022 | $26,456,000 | +40.7% | 227,506 | +82.3% | 0.03% | -30.0% |
| Q4 2021 | $18,806,000 | -48.1% | 124,821 | -58.9% | 0.04% | -56.5% |
| Q3 2021 | $36,269,000 | +3.4% | 303,811 | -15.6% | 0.09% | -6.1% |
| Q2 2021 | $35,066,000 | +36.9% | 360,020 | +24.1% | 0.10% | +10.1% |
| Q1 2021 | $25,610,000 | +25.0% | 290,203 | +35.5% | 0.09% | +17.1% |
| Q4 2020 | $20,485,000 | +25.0% | 214,096 | +48.0% | 0.08% | -7.3% |
| Q3 2020 | $16,384,000 | +1538.4% | 144,696 | +1331.8% | 0.08% | +1266.7% |
| Q2 2020 | $1,000,000 | – | 10,106 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |